[Bacteremias in immunosuppressed patients].
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D018805:Sepsis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents
Bacteremias em pacientes imunossuprimidos.